Special Issue "Functional Products Used in Alleviation of Oxidative Stress Diseases and Interaction with Human Microbiota 2.0"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 13678
Interests: in vitro; natural product; bioavailability; antioxidant; probiotic; microbiota
Special Issues, Collections and Topics in MDPI journals
Special Issue in Applied Sciences: Bioactive Compounds from Natural Products: Separation, Characterization and Applications
Special Issue in Applied Sciences: Microbiota Restoration and Modulation by Functional Products
Special Issue in Applied Sciences: Bioactive Compounds from Natural Products - Volume II
Special Issue in Nutraceuticals: Natural Nutraceuticals in Actual Therapeutic Strategies
Special Issue in Pharmaceutics: Delivery Systems on the Antioxidant Activity of Natural Bioactive Compounds
Special Issue in Life: Current Updates on Microbiota Restoration and Modulation by Functional Products
Functional products (such as probiotics, prebiotics, dietary fibers, plant extracts, etc.) are useful tools in reducing or alleviating the pathological effects of oxidative stress. Moreover, postbiotics and parapostbiotics have emerged as new products for modulating microbiota bioactivity. The development of innovative products is a significant research area that is providing evidence for disease control and the prevention of degenerative pathologies. Thus, for this Special Issue, we aim to publish recent studies presenting possible in vitro and in vivo evidence of a modulation response through the microbiota pattern. You are also invited to contribute research based on the effect of different drugs that are used in degenerative pathologies and possible interactions with the human microbiota. Side effects are significant in disease management and interactions with associated pathologies. We would like to encourage you to send papers on these and other related aspects relevant to the issue.
Prof. Dr. Emanuel Vamanu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- product administration
- functional quality
- microbiota modulation
- immunomodulatory effects
- pro-, pre-, synbiotic nutraceuticals
- free radicals